- Home
- KOS vs DAWN Comparison
KOS vs DAWN Comparison
Compare KOS & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOS
- DAWN
- Stock Information
- Founded
- KOS 2003
- DAWN 2018
- Country
- KOS United States
- DAWN United States
- Employees
- KOS N/A
- DAWN N/A
- Industry
- KOS Oil & Gas Production
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- KOS Energy
- DAWN Health Care
- Exchange
- KOS Nasdaq
- DAWN Nasdaq
- Market Cap
- KOS 822.2M
- DAWN 658.9M
- IPO Year
- KOS 2011
- DAWN 2021
- Fundamental
- Price
- KOS $2.21
- DAWN $7.23
- Analyst Decision
- KOS Buy
- DAWN Strong Buy
- Analyst Count
- KOS 6
- DAWN 6
- Target Price
- KOS $4.52
- DAWN $30.17
- AVG Volume (30 Days)
- KOS 7.6M
- DAWN 1.5M
- Earning Date
- KOS 08-04-2025
- DAWN 08-05-2025
- Dividend Yield
- KOS N/A
- DAWN N/A
- EPS Growth
- KOS N/A
- DAWN N/A
- EPS
- KOS N/A
- DAWN N/A
- Revenue
- KOS $1,546,854,000.00
- DAWN $161,922,000.00
- Revenue This Year
- KOS N/A
- DAWN $17.98
- Revenue Next Year
- KOS $11.57
- DAWN $49.50
- P/E Ratio
- KOS N/A
- DAWN N/A
- Revenue Growth
- KOS N/A
- DAWN N/A
- 52 Week Low
- KOS $1.39
- DAWN $6.08
- 52 Week High
- KOS $5.66
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- KOS 58.91
- DAWN 62.10
- Support Level
- KOS $1.95
- DAWN $6.32
- Resistance Level
- KOS $2.35
- DAWN $7.00
- Average True Range (ATR)
- KOS 0.12
- DAWN 0.31
- MACD
- KOS 0.02
- DAWN 0.06
- Stochastic Oscillator
- KOS 69.57
- DAWN 89.39
About KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.